Monroe Capital (MRCC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
20 Jan, 2026Executive summary
The document details a proposed merger between two business development companies, involving an asset sale and subsequent merger, with the surviving entity continuing operations under its existing management and investment strategy.
The transaction is structured so that one company sells all its investment assets for cash to an affiliate, then merges with the acquirer, with shareholders receiving shares based on a net asset value exchange ratio.
The merger is intended to be tax-free for shareholders, with the exchange ratio determined by the relative net asset values of the companies shortly before closing.
Both boards, following special committee recommendations and fairness opinions from independent financial advisors, unanimously recommend shareholder approval.
The combined company expects enhanced scale, diversification, operational synergies, and a temporary advisory fee waiver to benefit shareholders.
Voting matters and shareholder proposals
Shareholders of the acquiring company are asked to approve the issuance of new shares for the merger and to elect a new director from the target company.
Shareholders of the target company are asked to approve the asset sale and the merger.
Approval thresholds: a majority of votes cast for the share issuance and a plurality for the director election; a majority of outstanding shares for the asset sale and merger.
Abstentions and broker non-votes have no effect on the outcome for the acquirer, but count as votes against for the target.
Termination fees and expense reimbursements are specified if the transaction is not completed and a superior proposal is accepted.
Board of directors and corporate governance
The post-merger board will include two independent directors from the acquirer, one independent director from the target, and the acquirer's CEO.
The director nominee from the target company is subject to shareholder approval and contingent on the merger closing.
The acquirer's board is classified, with staggered three-year terms and removal only for cause by a supermajority.
Anti-takeover provisions, advance notice requirements, and limitations on shareholder actions are in place.
Latest events from Monroe Capital
- Both asset sale and merger proposals were approved by a majority of outstanding shares.MRCC
EGM 202613 Mar 2026 - Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCC
Proxy Filing11 Mar 2026 - Supplement updates proxy materials for a proposed transaction, referencing recent filings.MRCC
Proxy Filing6 Mar 2026 - Net investment income and NAV declined year-over-year, with merger expected to unlock value.MRCC
Q4 20255 Mar 2026 - Director election and share sale authorization approved; no shareholder questions raised.MRCC
AGM 20243 Feb 2026 - Adjusted NII rose to $0.31/share, covering the dividend as NAV and leverage declined.MRCC
Q2 20242 Feb 2026 - Dividend coverage strong, NAV dipped, non-accruals up, Wendel partnership adds $1B capital.MRCC
Q3 202414 Jan 2026 - Q4 income covered dividends; NAV dipped, but 2025 outlook targets growth and risk discipline.MRCC
Q4 202416 Dec 2025 - Shareholders to vote on unchanged advisory agreement after Wendel acquires 75% of Monroe.MRCC
Proxy Filing2 Dec 2025